                         SEQUENCE LISTING

<110>  Protalix Ltd.
       Hadasit Medical Research Services and Development Ltd.
       Ilan, Yaron
       Shaaltiel, Yoseph
       Hanania, Uri
       Kizhner, Tali
       Ariel, Tami
       Gingis-Velitski, Svetlana
 
<120>  USE OF PLANT CELLS EXPRESSING A TNFalpha POLYPEPTIDE INHIBITOR IN
        THERAPY

<130>  58408

<150>  US 61/773,392
<151>  2013-03-06

<160>  205   

<170>  PatentIn version 3.5

<210>  1
<211>  705
<212>  DNA
<213>  Artificial sequence

<220>
<223>  DNA encoding a TNFR2 derived sequence

<400>  1
cttccagctc aggttgcttt tactccatat gctccggagc caggatctac ttgtaggctt       60

agggaatact acgatcagac tgctcaaatg tgctgctcta agtgctctcc aggacagcac      120

gctaaggttt tctgcactaa gacttcagat actgtttgcg attcttgcga ggattctact      180

tacactcagc tttggaattg ggttccagag tgtctttctt gtggatctag gtgctcttct      240

gatcaggttg agactcaggc ttgtactagg gagcagaata ggatttgtac ttgcaggcca      300

ggatggtatt gtgctctttc taagcaagag ggatgtaggc tttgtgctcc acttagaaag      360

tgcaggcctg gttttggagt tgctagacca ggaactgaga cttctgacgt tgtttgcaag      420

ccatgtgctc caggaacttt ctctaatact acttcttcta ctgatatttg caggccacat      480

caaatttgca atgttgttgc tattccaggt aatgcttcta tggatgctgt ttgcacttct      540

acttctccaa ctaggtctat ggctccagga gctgttcatc ttccacaacc agtttctact      600

aggtcacaac atactcagcc aactccagaa ccatctactg ctccatctac ttcattcctt      660

ttgccaatgg gaccatctcc accagctgaa ggatctactg gagat                      705


<210>  2
<211>  235
<212>  PRT
<213>  Artificial sequence

<220>
<223>  TNFR2 derived sequence

<400>  2

Leu Pro Ala Gln Val Ala Phe Thr Pro Tyr Ala Pro Glu Pro Gly Ser 
1               5                   10                  15      


Thr Cys Arg Leu Arg Glu Tyr Tyr Asp Gln Thr Ala Gln Met Cys Cys 
            20                  25                  30          


Ser Lys Cys Ser Pro Gly Gln His Ala Lys Val Phe Cys Thr Lys Thr 
        35                  40                  45              


Ser Asp Thr Val Cys Asp Ser Cys Glu Asp Ser Thr Tyr Thr Gln Leu 
    50                  55                  60                  


Trp Asn Trp Val Pro Glu Cys Leu Ser Cys Gly Ser Arg Cys Ser Ser 
65                  70                  75                  80  


Asp Gln Val Glu Thr Gln Ala Cys Thr Arg Glu Gln Asn Arg Ile Cys 
                85                  90                  95      


Thr Cys Arg Pro Gly Trp Tyr Cys Ala Leu Ser Lys Gln Glu Gly Cys 
            100                 105                 110         


Arg Leu Cys Ala Pro Leu Arg Lys Cys Arg Pro Gly Phe Gly Val Ala 
        115                 120                 125             


Arg Pro Gly Thr Glu Thr Ser Asp Val Val Cys Lys Pro Cys Ala Pro 
    130                 135                 140                 


Gly Thr Phe Ser Asn Thr Thr Ser Ser Thr Asp Ile Cys Arg Pro His 
145                 150                 155                 160 


Gln Ile Cys Asn Val Val Ala Ile Pro Gly Asn Ala Ser Met Asp Ala 
                165                 170                 175     


Val Cys Thr Ser Thr Ser Pro Thr Arg Ser Met Ala Pro Gly Ala Val 
            180                 185                 190         


His Leu Pro Gln Pro Val Ser Thr Arg Ser Gln His Thr Gln Pro Thr 
        195                 200                 205             


Pro Glu Pro Ser Thr Ala Pro Ser Thr Ser Phe Leu Leu Pro Met Gly 
    210                 215                 220                 


Pro Ser Pro Pro Ala Glu Gly Ser Thr Gly Asp 
225                 230                 235 


<210>  3
<211>  81
<212>  DNA
<213>  Artificial sequence

<220>
<223>  N. plumbaginifolia Calreticulin protein derived signal peptide 
       encoding sequence

<400>  3
atggctactc aaaggagggc taatccatct tctcttcatc ttattactgt tttctctctt       60

cttgttgctg ttgtttctgc a                                                 81


<210>  4
<211>  27
<212>  PRT
<213>  Artificial sequence

<220>
<223>  N. plumbaginifolia Calreticulin protein derived signal peptide

<400>  4

Met Ala Thr Gln Arg Arg Ala Asn Pro Ser Ser Leu His Leu Ile Thr 
1               5                   10                  15      


Val Phe Ser Leu Leu Val Ala Val Val Ser Ala 
            20                  25          


<210>  5
<211>  1506
<212>  DNA
<213>  Artificial sequence

<220>
<223>  prh TNFR2:Fc (PRX106) encoding sequence

<400>  5
atggctactc aaaggagggc taatccatct tctcttcatc ttattactgt tttctctctt       60

cttgttgctg ttgtttctgc acttccagct caggttgctt ttactccata tgctccggag      120

ccaggatcta cttgtaggct tagggaatac tacgatcaga ctgctcaaat gtgctgctct      180

aagtgctctc caggacagca cgctaaggtt ttctgcacta agacttcaga tactgtttgc      240

gattcttgcg aggattctac ttacactcag ctttggaatt gggttccaga gtgtctttct      300

tgtggatcta ggtgctcttc tgatcaggtt gagactcagg cttgtactag ggagcagaat      360

aggatttgta cttgcaggcc aggatggtat tgtgctcttt ctaagcaaga gggatgtagg      420

ctttgtgctc cacttagaaa gtgcaggcct ggttttggag ttgctagacc aggaactgag      480

acttctgacg ttgtttgcaa gccatgtgct ccaggaactt tctctaatac tacttcttct      540

actgatattt gcaggccaca tcaaatttgc aatgttgttg ctattccagg taatgcttct      600

atggatgctg tttgcacttc tacttctcca actaggtcta tggctccagg agctgttcat      660

cttccacaac cagtttctac taggtcacaa catactcagc caactccaga accatctact      720

gctccatcta cttcattcct tttgccaatg ggaccatctc caccagctga aggatctact      780

ggagatgagc caaagtcttg cgataagact catacttgtc caccatgtcc agctccagaa      840

cttcttggag gaccatctgt tttccttttc ccaccaaagc caaaggatac tcttatgatt      900

tctaggactc cagaggttac ttgcgttgtt gttgatgttt cacatgaaga tccagaggtg      960

aagttcaatt ggtacgttga tggagttgag gttcataatg ctaagactaa gccaagggag     1020

gagcaataca attcaacata cagggttgtt tctgttctta ctgttcttca tcaagattgg     1080

cttaatggaa aggaatacaa gtgcaaggtt tctaataagg ctttgccagc accaattgaa     1140

aagactattt ctaaggctaa gggacaacca agagagccac aagtttacac tcttccacca     1200

tctagggagg agatgactaa gaatcaagtt tctcttactt gccttgttaa gggattctac     1260

ccatctgata ttgctgttga gtgggagtct aacggacagc ctgagaataa ttacaagact     1320

actccaccag ttcttgattc tgatggatct ttcttccttt actctaagtt gactgttgat     1380

aagtctaggt ggcaacaggg aaatgttttc tcttgctctg ttatgcatga ggctcttcat     1440

aatcattaca ctcagaaatc actttctctt tctccaggta agagtgagaa ggacgagctc     1500

tgatga                                                                1506


<210>  6
<211>  500
<212>  PRT
<213>  Artificial sequence

<220>
<223>  prh TNFR2:Fc (PRX106) polypeptide

<400>  6

Met Ala Thr Gln Arg Arg Ala Asn Pro Ser Ser Leu His Leu Ile Thr 
1               5                   10                  15      


Val Phe Ser Leu Leu Val Ala Val Val Ser Ala Leu Pro Ala Gln Val 
            20                  25                  30          


Ala Phe Thr Pro Tyr Ala Pro Glu Pro Gly Ser Thr Cys Arg Leu Arg 
        35                  40                  45              


Glu Tyr Tyr Asp Gln Thr Ala Gln Met Cys Cys Ser Lys Cys Ser Pro 
    50                  55                  60                  


Gly Gln His Ala Lys Val Phe Cys Thr Lys Thr Ser Asp Thr Val Cys 
65                  70                  75                  80  


Asp Ser Cys Glu Asp Ser Thr Tyr Thr Gln Leu Trp Asn Trp Val Pro 
                85                  90                  95      


Glu Cys Leu Ser Cys Gly Ser Arg Cys Ser Ser Asp Gln Val Glu Thr 
            100                 105                 110         


Gln Ala Cys Thr Arg Glu Gln Asn Arg Ile Cys Thr Cys Arg Pro Gly 
        115                 120                 125             


Trp Tyr Cys Ala Leu Ser Lys Gln Glu Gly Cys Arg Leu Cys Ala Pro 
    130                 135                 140                 


Leu Arg Lys Cys Arg Pro Gly Phe Gly Val Ala Arg Pro Gly Thr Glu 
145                 150                 155                 160 


Thr Ser Asp Val Val Cys Lys Pro Cys Ala Pro Gly Thr Phe Ser Asn 
                165                 170                 175     


Thr Thr Ser Ser Thr Asp Ile Cys Arg Pro His Gln Ile Cys Asn Val 
            180                 185                 190         


Val Ala Ile Pro Gly Asn Ala Ser Met Asp Ala Val Cys Thr Ser Thr 
        195                 200                 205             


Ser Pro Thr Arg Ser Met Ala Pro Gly Ala Val His Leu Pro Gln Pro 
    210                 215                 220                 


Val Ser Thr Arg Ser Gln His Thr Gln Pro Thr Pro Glu Pro Ser Thr 
225                 230                 235                 240 


Ala Pro Ser Thr Ser Phe Leu Leu Pro Met Gly Pro Ser Pro Pro Ala 
                245                 250                 255     


Glu Gly Ser Thr Gly Asp Glu Pro Lys Ser Cys Asp Lys Thr His Thr 
            260                 265                 270         


Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly Pro Ser Val Phe 
        275                 280                 285             


Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro 
    290                 295                 300                 


Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro Glu Val 
305                 310                 315                 320 


Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr 
                325                 330                 335     


Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val 
            340                 345                 350         


Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys 
        355                 360                 365             


Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser 
    370                 375                 380                 


Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro 
385                 390                 395                 400 


Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr Cys Leu Val 
                405                 410                 415     


Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly 
            420                 425                 430         


Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp 
        435                 440                 445             


Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp 
    450                 455                 460                 


Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu His 
465                 470                 475                 480 


Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys Ser Glu 
                485                 490                 495     


Lys Asp Glu Leu 
            500 


<210>  7
<211>  473
<212>  PRT
<213>  Artificial sequence

<220>
<223>  prh TNFR2:Fc (PRX106) mature polypeptide

<400>  7

Leu Pro Ala Gln Val Ala Phe Thr Pro Tyr Ala Pro Glu Pro Gly Ser 
1               5                   10                  15      


Thr Cys Arg Leu Arg Glu Tyr Tyr Asp Gln Thr Ala Gln Met Cys Cys 
            20                  25                  30          


Ser Lys Cys Ser Pro Gly Gln His Ala Lys Val Phe Cys Thr Lys Thr 
        35                  40                  45              


Ser Asp Thr Val Cys Asp Ser Cys Glu Asp Ser Thr Tyr Thr Gln Leu 
    50                  55                  60                  


Trp Asn Trp Val Pro Glu Cys Leu Ser Cys Gly Ser Arg Cys Ser Ser 
65                  70                  75                  80  


Asp Gln Val Glu Thr Gln Ala Cys Thr Arg Glu Gln Asn Arg Ile Cys 
                85                  90                  95      


Thr Cys Arg Pro Gly Trp Tyr Cys Ala Leu Ser Lys Gln Glu Gly Cys 
            100                 105                 110         


Arg Leu Cys Ala Pro Leu Arg Lys Cys Arg Pro Gly Phe Gly Val Ala 
        115                 120                 125             


Arg Pro Gly Thr Glu Thr Ser Asp Val Val Cys Lys Pro Cys Ala Pro 
    130                 135                 140                 


Gly Thr Phe Ser Asn Thr Thr Ser Ser Thr Asp Ile Cys Arg Pro His 
145                 150                 155                 160 


Gln Ile Cys Asn Val Val Ala Ile Pro Gly Asn Ala Ser Met Asp Ala 
                165                 170                 175     


Val Cys Thr Ser Thr Ser Pro Thr Arg Ser Met Ala Pro Gly Ala Val 
            180                 185                 190         


His Leu Pro Gln Pro Val Ser Thr Arg Ser Gln His Thr Gln Pro Thr 
        195                 200                 205             


Pro Glu Pro Ser Thr Ala Pro Ser Thr Ser Phe Leu Leu Pro Met Gly 
    210                 215                 220                 


Pro Ser Pro Pro Ala Glu Gly Ser Thr Gly Asp Glu Pro Lys Ser Cys 
225                 230                 235                 240 


Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly 
                245                 250                 255     


Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met 
            260                 265                 270         


Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His 
        275                 280                 285             


Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val 
    290                 295                 300                 


His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr 
305                 310                 315                 320 


Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly 
                325                 330                 335     


Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile 
            340                 345                 350         


Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val 
        355                 360                 365             


Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser 
    370                 375                 380                 


Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu 
385                 390                 395                 400 


Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro 
                405                 410                 415     


Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val 
            420                 425                 430         


Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met 
        435                 440                 445             


His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser 
    450                 455                 460                 


Pro Gly Lys Ser Glu Lys Asp Glu Leu 
465                 470             


<210>  8
<211>  696
<212>  DNA
<213>  Artificial sequence

<220>
<223>  IgG1-FC encoding sequence

<400>  8
gagccaaagt cttgcgataa gactcatact tgtccaccat gtccagctcc agaacttctt       60

ggaggaccat ctgttttcct tttcccacca aagccaaagg atactcttat gatttctagg      120

actccagagg ttacttgcgt tgttgttgat gtttcacatg aagatccaga ggtgaagttc      180

aattggtacg ttgatggagt tgaggttcat aatgctaaga ctaagccaag ggaggagcaa      240

tacaattcaa catacagggt tgtttctgtt cttactgttc ttcatcaaga ttggcttaat      300

ggaaaggaat acaagtgcaa ggtttctaat aaggctttgc cagcaccaat tgaaaagact      360

atttctaagg ctaagggaca accaagagag ccacaagttt acactcttcc accatctagg      420

gaggagatga ctaagaatca agtttctctt acttgccttg ttaagggatt ctacccatct      480

gatattgctg ttgagtggga gtctaacgga cagcctgaga ataattacaa gactactcca      540

ccagttcttg attctgatgg atctttcttc ctttactcta agttgactgt tgataagtct      600

aggtggcaac agggaaatgt tttctcttgc tctgttatgc atgaggctct tcataatcat      660

tacactcaga aatcactttc tctttctcca ggtaag                                696


<210>  9
<211>  232
<212>  PRT
<213>  Artificial sequence

<220>
<223>  IgG1-FC

<400>  9

Glu Pro Lys Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala 
1               5                   10                  15      


Pro Glu Leu Leu Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro 
            20                  25                  30          


Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val 
        35                  40                  45              


Val Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val 
    50                  55                  60                  


Asp Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln 
65                  70                  75                  80  


Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln 
                85                  90                  95      


Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala 
            100                 105                 110         


Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro 
        115                 120                 125             


Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr 
    130                 135                 140                 


Lys Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser 
145                 150                 155                 160 


Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr 
                165                 170                 175     


Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr 
            180                 185                 190         


Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe 
        195                 200                 205             


Ser Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys 
    210                 215                 220                 


Ser Leu Ser Leu Ser Pro Gly Lys 
225                 230         


<210>  10
<211>  467
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Etanercept polypeptide

<400>  10

Leu Pro Ala Gln Val Ala Phe Thr Pro Tyr Ala Pro Glu Pro Gly Ser 
1               5                   10                  15      


Thr Cys Arg Leu Arg Glu Tyr Tyr Asp Gln Thr Ala Gln Met Cys Cys 
            20                  25                  30          


Ser Lys Cys Ser Pro Gly Gln His Ala Lys Val Phe Cys Thr Lys Thr 
        35                  40                  45              


Ser Asp Thr Val Cys Asp Ser Cys Glu Asp Ser Thr Tyr Thr Gln Leu 
    50                  55                  60                  


Trp Asn Trp Val Pro Glu Cys Leu Ser Cys Gly Ser Arg Cys Ser Ser 
65                  70                  75                  80  


Asp Gln Val Glu Thr Gln Ala Cys Thr Arg Glu Gln Asn Arg Ile Cys 
                85                  90                  95      


Thr Cys Arg Pro Gly Trp Tyr Cys Ala Leu Ser Lys Gln Glu Gly Cys 
            100                 105                 110         


Arg Leu Cys Ala Pro Leu Arg Lys Cys Arg Pro Gly Phe Gly Val Ala 
        115                 120                 125             


Arg Pro Gly Thr Glu Thr Ser Asp Val Val Cys Lys Pro Cys Ala Pro 
    130                 135                 140                 


Gly Thr Phe Ser Asn Thr Thr Ser Ser Thr Asp Ile Cys Arg Pro His 
145                 150                 155                 160 


Gln Ile Cys Asn Val Val Ala Ile Pro Gly Asn Ala Ser Met Asp Ala 
                165                 170                 175     


Val Cys Thr Ser Thr Ser Pro Thr Arg Ser Met Ala Pro Gly Ala Val 
            180                 185                 190         


His Leu Pro Gln Pro Val Ser Thr Arg Ser Gln His Thr Gln Pro Thr 
        195                 200                 205             


Pro Glu Pro Ser Thr Ala Pro Ser Thr Ser Phe Leu Leu Pro Met Gly 
    210                 215                 220                 


Pro Ser Pro Pro Ala Glu Gly Ser Thr Gly Asp Glu Pro Lys Ser Cys 
225                 230                 235                 240 


Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly 
                245                 250                 255     


Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met 
            260                 265                 270         


Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His 
        275                 280                 285             


Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val 
    290                 295                 300                 


His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr 
305                 310                 315                 320 


Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly 
                325                 330                 335     


Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile 
            340                 345                 350         


Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val 
        355                 360                 365             


Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser 
    370                 375                 380                 


Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu 
385                 390                 395                 400 


Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro 
                405                 410                 415     


Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val 
            420                 425                 430         


Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met 
        435                 440                 445             


His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser 
    450                 455                 460                 


Pro Gly Lys 
465         


<210>  11
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  TNFR2 derived sequence

<400>  11

Leu Cys Ala Pro 
1               


<210>  12
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  TNFR2 derived sequence

<400>  12

Val Phe Cys Thr 
1               


<210>  13
<211>  18
<212>  PRT
<213>  Artificial sequence

<220>
<223>  TNFR2 derived sequence


<220>
<221>  misc_feature
<222>  (8)..(8)
<223>  Xaa can be any naturally occurring amino acid

<400>  13

Leu Pro Ala Gln Val Ala Phe Xaa Pro Tyr Ala Pro Glu Pro Gly Ser 
1               5                   10                  15      


Thr Cys 
        


<210>  14
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  ER retention signal peptide

<400>  14

His Asp Glu Leu 
1               


<210>  15
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  ER retention signal peptide

<400>  15

Lys Asp Glu Leu 
1               


<210>  16
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  ER retention signal peptide

<400>  16

Ser Glu Lys Asp Glu Leu 
1               5       


<210>  17
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  TNFR2 derived sequence

<400>  17

Leu Pro Ala Gln Val Ala Phe Thr Pro Tyr Ala Pro Glu Pro Gly Ser 
1               5                   10                  15      


Thr Cys 
        


<210>  18
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  18

Leu Pro Ala Gln Val 
1               5   


<210>  19
<211>  23
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  19

Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu 
1               5                   10                  15      


His Asn His Tyr Thr Gln Lys 
            20              


<210>  20
<211>  23
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  20

Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu 
1               5                   10                  15      


His Asn His Tyr Thr Gln Lys 
            20              


<210>  21
<211>  23
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  21

Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln 
1               5                   10                  15      


Pro Glu Asn Asn Tyr Lys Thr 
            20              


<210>  22
<211>  23
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  22

Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His 
1               5                   10                  15      


Gln Asp Trp Leu Asn Gly Lys 
            20              


<210>  23
<211>  24
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  23

Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu 
1               5                   10                  15      


His Asn His Tyr Thr Gln Lys Ser 
            20                  


<210>  24
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  24

Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys 
1               5                   10                  15      


Glu Tyr Lys Cys 
            20  


<210>  25
<211>  19
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  25

Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys 
1               5                   10                  15      


Glu Tyr Lys 
            


<210>  26
<211>  37
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  26

Ser Gln His Thr Gln Pro Thr Pro Glu Pro Ser Thr Ala Pro Ser Thr 
1               5                   10                  15      


Ser Phe Leu Leu Pro Met Gly Pro Ser Pro Pro Ala Glu Gly Ser Thr 
            20                  25                  30          


Gly Asp Glu Pro Lys 
        35          


<210>  27
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  27

Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu 
1               5                   10                  15      


His Asn His Tyr 
            20  


<210>  28
<211>  31
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  28

Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu 
1               5                   10                  15      


Leu Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp 
            20                  25                  30      


<210>  29
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  29

Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu 
1               5                   10                  15      


Glu Met Thr Lys 
            20  


<210>  30
<211>  23
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  30

Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln 
1               5                   10                  15      


Pro Glu Asn Asn Tyr Lys Thr 
            20              


<210>  31
<211>  19
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  31

Leu Pro Ala Gln Val Ala Phe Thr Pro Tyr Ala Pro Glu Pro Gly Ser 
1               5                   10                  15      


Thr Cys Arg 
            


<210>  32
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  32

Glu Ala Leu His Asn His Tyr Thr Gln Lys 
1               5                   10  


<210>  33
<211>  22
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  33

Gln Asn Arg Ile Cys Thr Cys Arg Pro Gly Trp Tyr Cys Ala Leu Ser 
1               5                   10                  15      


Lys Gln Glu Gly Cys Arg 
            20          


<210>  34
<211>  23
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  34

Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu 
1               5                   10                  15      


His Asn His Tyr Thr Gln Lys 
            20              


<210>  35
<211>  37
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  35

Ser Gln His Thr Gln Pro Thr Pro Glu Pro Ser Thr Ala Pro Ser Thr 
1               5                   10                  15      


Ser Phe Leu Leu Pro Met Gly Pro Ser Pro Pro Ala Glu Gly Ser Thr 
            20                  25                  30          


Gly Asp Glu Pro Lys 
        35          


<210>  36
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  36

Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu 
1               5                   10                  15      


Glu Met Thr Lys 
            20  


<210>  37
<211>  22
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  37

Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln 
1               5                   10                  15      


Pro Glu Asn Asn Tyr Lys 
            20          


<210>  38
<211>  37
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  38

Ser Gln His Thr Gln Pro Thr Pro Glu Pro Ser Thr Ala Pro Ser Thr 
1               5                   10                  15      


Ser Phe Leu Leu Pro Met Gly Pro Ser Pro Pro Ala Glu Gly Ser Thr 
            20                  25                  30          


Gly Asp Glu Pro Lys 
        35          


<210>  39
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  39

Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys 
1               5                   10                  15      


<210>  40
<211>  31
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  40

Thr Tyr Thr Gln Leu Trp Asn Trp Val Pro Glu Cys Leu Ser Cys Gly 
1               5                   10                  15      


Ser Arg Cys Ser Ser Asp Gln Val Glu Thr Gln Ala Cys Thr Arg 
            20                  25                  30      


<210>  41
<211>  23
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  41

Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu 
1               5                   10                  15      


His Asn His Tyr Thr Gln Lys 
            20              


<210>  42
<211>  23
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  42

Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln 
1               5                   10                  15      


Pro Glu Asn Asn Tyr Lys Thr 
            20              


<210>  43
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  43

Val Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys 
1               5                   10              


<210>  44
<211>  24
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  44

Pro Ser Thr Ser Phe Leu Leu Pro Met Gly Pro Ser Pro Pro Ala Glu 
1               5                   10                  15      


Gly Ser Thr Gly Asp Glu Pro Lys 
            20                  


<210>  45
<211>  19
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  45

Leu Pro Ala Gln Val Ala Phe Thr Pro Tyr Ala Pro Glu Pro Gly Ser 
1               5                   10                  15      


Thr Cys Arg 
            


<210>  46
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  46

Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu 
1               5                   10                  


<210>  47
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  47

Leu Ser Leu Ser Pro Gly Lys 
1               5           


<210>  48
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  48

Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys 
1               5                   10                  15      


Asn 
    


<210>  49
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  49

Ser Met Ala Pro Gly Ala Val His Leu Pro Gln 
1               5                   10      


<210>  50
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  50

Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser 
1               5                   10                  15      


Lys 
    


<210>  51
<211>  23
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  51

Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu 
1               5                   10                  15      


His Asn His Tyr Thr Gln Lys 
            20              


<210>  52
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  52

Ser Met Ala Pro Gly Ala Val His 
1               5               


<210>  53
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  53

Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys 
1               5                   10                  


<210>  54
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  54

Val Val Ser Val Leu Thr Val Leu His 
1               5                   


<210>  55
<211>  37
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  55

Ser Gln His Thr Gln Pro Thr Pro Glu Pro Ser Thr Ala Pro Ser Thr 
1               5                   10                  15      


Ser Phe Leu Leu Pro Met Gly Pro Ser Pro Pro Ala Glu Gly Ser Thr 
            20                  25                  30          


Gly Asp Glu Pro Lys 
        35          


<210>  56
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  56

Gly Gln Pro Arg Glu Pro Gln Val Tyr 
1               5                   


<210>  57
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  57

Ala Gln Val Ala Phe Thr Pro Tyr Ala Pro Glu Pro Gly Ser Thr Cys 
1               5                   10                  15      


Arg 
    


<210>  58
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  58

Cys Ala Pro Leu Arg Lys 
1               5       


<210>  59
<211>  26
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  59

Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys 
1               5                   10                  15      


Asn Gln Val Ser Leu Thr Cys Leu Val Lys 
            20                  25      


<210>  60
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  60

Ser Met Ala Pro Gly Ala Val His 
1               5               


<210>  61
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  61

Val Val Ser Val Leu Thr Val Leu His Gln Asp 
1               5                   10      


<210>  62
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  62

Leu Phe Pro Pro Lys Pro Lys 
1               5           


<210>  63
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  63

Gly Ser Phe Phe Leu Tyr Ser Lys 
1               5               


<210>  64
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  64

Ile Cys Thr Cys Arg Pro Gly Trp Tyr 
1               5                   


<210>  65
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  65

Ser Gln His Thr Gln Pro Thr Pro Glu Pro Ser 
1               5                   10      


<210>  66
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  66

Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr 
1               5                   10                  15      


Lys 
    


<210>  67
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  67

Gln Val Glu Thr Gln Ala Cys Thr Arg 
1               5                   


<210>  68
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  68

Ser Leu Ser Leu Ser Pro Gly Lys 
1               5               


<210>  69
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  69

Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys 
1               5                   10  


<210>  70
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  70

Lys Ala Leu Pro Ala Pro Ile Glu Lys 
1               5                   


<210>  71
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  71

Ala Leu Pro Ala Pro Ile Glu Lys 
1               5               


<210>  72
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  72

Ala Val Cys Thr Ser Thr Ser Pro Thr Arg 
1               5                   10  


<210>  73
<211>  18
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  73

Ser Gln His Thr Gln Pro Thr Pro Glu Pro Ser Thr Ala Pro Ser Thr 
1               5                   10                  15      


Ser Phe 
        


<210>  74
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  74

Gln Val Ser Leu Thr Cys Leu Val Lys 
1               5                   


<210>  75
<211>  23
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  75

Leu Arg Glu Tyr Tyr Asp Gln Thr Ala Gln Met Cys Cys Ser Lys Cys 
1               5                   10                  15      


Ser Pro Gly Gln His Ala Lys 
            20              


<210>  76
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  76

Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu 
1               5                   10                  15      


His 
    


<210>  77
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  77

Asp Thr Leu Met Ile Ser Arg 
1               5           


<210>  78
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  78

Pro Met Gly Pro Ser Pro Pro Ala Glu Gly Ser Thr Gly Asp Glu Pro 
1               5                   10                  15      


Lys 
    


<210>  79
<211>  19
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  79

Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly Pro 
1               5                   10                  15      


Ser Val Phe 
            


<210>  80
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  80

Asp Thr Leu Met Ile Ser Arg 
1               5           


<210>  81
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  81

Ser Asp Gln Val Glu Thr Gln Ala Cys Thr Arg 
1               5                   10      


<210>  82
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  82

Lys Cys Arg Pro Gly Phe Gly Val Ala Arg 
1               5                   10  


<210>  83
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  83

Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys 
1               5                   10          


<210>  84
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  84

Tyr Val Asp Gly Val Glu Val His Asn Ala Lys 
1               5                   10      


<210>  85
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  85

Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe 
1               5                   10              


<210>  86
<211>  26
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  86

Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly Pro 
1               5                   10                  15      


Ser Val Phe Leu Phe Pro Pro Lys Pro Lys 
            20                  25      


<210>  87
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  87

Pro Ser Pro Pro Ala Glu Gly Ser Thr Gly Asp Glu Pro Lys 
1               5                   10                  


<210>  88
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  88

Ser Leu Ser Leu Ser Pro Gly Lys Ser Glu Lys Asp 
1               5                   10          


<210>  89
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  89

Met Ala Pro Gly Ala Val His Leu Pro Gln Pro Val Ser Thr Arg 
1               5                   10                  15  


<210>  90
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  90

Val Asp Gly Val Glu Val His Asn Ala Lys 
1               5                   10  


<210>  91
<211>  23
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  91

Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu 
1               5                   10                  15      


Leu Gly Gly Pro Ser Val Phe 
            20              


<210>  92
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  92

Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys 
1               5                   10                  15      


<210>  93
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  93

Ser Leu Ser Leu Ser Pro Gly Lys Ser Glu Lys 
1               5                   10      


<210>  94
<211>  22
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  94

Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly Pro Ser Val Phe Leu 
1               5                   10                  15      


Phe Pro Pro Lys Pro Lys 
            20          


<210>  95
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  95

Ser Phe Phe Leu Tyr Ser Lys 
1               5           


<210>  96
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  96

Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys 
1               5                   10                  


<210>  97
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  97

Phe Leu Leu Pro Met Gly Pro Ser Pro Pro Ala Glu Gly Ser Thr Gly 
1               5                   10                  15      


Asp Glu Pro Lys 
            20  


<210>  98
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  98

Asp Ala Val Cys Thr Ser Thr Ser Pro Thr Arg 
1               5                   10      


<210>  99
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  99

Asn Gln Val Ser Leu Thr Cys Leu Val Lys 
1               5                   10  


<210>  100
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  100

Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly 
1               5                   10      


<210>  101
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  101

Ser Leu Ser Pro Gly Lys Ser Glu Lys 
1               5                   


<210>  102
<211>  19
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  102

Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro 
1               5                   10                  15      


Glu Val Lys 
            


<210>  103
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  103

Leu Arg Glu Tyr Tyr Asp Gln Thr Ala Gln Met 
1               5                   10      


<210>  104
<211>  22
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  104

Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln 
1               5                   10                  15      


Pro Glu Asn Asn Tyr Lys 
            20          


<210>  105
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  105

Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn 
1               5                   10          


<210>  106
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  106

Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn 
1               5                   10                  


<210>  107
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  107

Ser Gln His Thr Gln Pro Thr Pro Glu Pro Ser Thr Ala Pro Ser Thr 
1               5                   10                  15      


<210>  108
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  108

Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp 
1               5                   10                  15      


Pro Glu Val Lys 
            20  


<210>  109
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  109

Ser Leu Ser Leu Ser Pro Gly Lys Ser 
1               5                   


<210>  110
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  110

Leu Ser Pro Gly Lys Ser Glu Lys Asp Glu Leu 
1               5                   10      


<210>  111
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  111

Leu Pro Gln Pro Val Ser Thr Arg 
1               5               


<210>  112
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  112

Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr 
1               5                   10                  15  


<210>  113
<211>  19
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  113

Thr Ser Asp Thr Val Cys Asp Ser Cys Glu Asp Ser Thr Tyr Thr Gln 
1               5                   10                  15      


Leu Trp Asn 
            


<210>  114
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  114

Ala Leu Pro Ala Gln Val Ala Phe Thr Pro Tyr Ala Pro Glu Pro Gly 
1               5                   10                  15      


Ser Thr Cys Arg 
            20  


<210>  115
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  115

Glu Glu Gln Tyr Asn Ser Thr Tyr Arg 
1               5                   


<210>  116
<211>  30
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  116

Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu 
1               5                   10                  15      


Leu Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys 
            20                  25                  30  


<210>  117
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  117

Cys Ser Pro Gly Gln His Ala Lys Val Phe Cys Thr Lys 
1               5                   10              


<210>  118
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  118

Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp 
1               5                   10                  15  


<210>  119
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  119

Ser Met Ala Pro Gly Ala Val His Leu Pro Gln Pro Val 
1               5                   10              


<210>  120
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  120

Thr Cys Arg Pro Gly Trp Tyr Cys Ala Leu Ser Lys 
1               5                   10          


<210>  121
<211>  24
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  121

Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly Pro Ser Val 
1               5                   10                  15      


Phe Leu Phe Pro Pro Lys Pro Lys 
            20                  


<210>  122
<211>  30
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  122

Thr Ser Asp Thr Val Cys Asp Ser Cys Glu Asp Ser Thr Tyr Thr Gln 
1               5                   10                  15      


Leu Trp Asn Trp Val Pro Glu Cys Leu Ser Cys Gly Ser Arg 
            20                  25                  30  


<210>  123
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  123

Leu Cys Ala Pro Leu Arg Lys 
1               5           


<210>  124
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  124

Ser Pro Pro Ala Glu Gly Ser Thr Gly Asp Glu Pro Lys 
1               5                   10              


<210>  125
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  125

Trp Val Pro Glu Cys Leu Ser Cys Gly Ser Arg 
1               5                   10      


<210>  126
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  126

Gly Pro Ser Pro Pro Ala Glu Gly Ser Thr Gly Asp Glu Pro Lys 
1               5                   10                  15  


<210>  127
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  127

Ser Ser Asp Gln Val Glu Thr Gln Ala Cys Thr Arg 
1               5                   10          


<210>  128
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  128

Glu Glu Gln Tyr Asn Ser Thr Tyr Arg 
1               5                   


<210>  129
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  129

Val Ala Phe Thr Pro Tyr Ala Pro Glu Pro Gly Ser Thr Cys Arg 
1               5                   10                  15  


<210>  130
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  130

Pro Gly Trp Tyr Cys Ala Leu Ser Lys 
1               5                   


<210>  131
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  131

Cys Arg Pro Gly Phe Gly Val Ala Arg 
1               5                   


<210>  132
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  132

Ser Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys 
1               5                   10                  15      


<210>  133
<211>  19
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  133

Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys 
1               5                   10                  15      


Glu Tyr Lys 
            


<210>  134
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  134

Leu Cys Ala Pro Leu Arg 
1               5       


<210>  135
<211>  26
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  135

Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys 
1               5                   10                  15      


Asn Gln Val Ser Leu Thr Cys Leu Val Lys 
            20                  25      


<210>  136
<211>  19
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  136

Leu Leu Pro Met Gly Pro Ser Pro Pro Ala Glu Gly Ser Thr Gly Asp 
1               5                   10                  15      


Glu Pro Lys 
            


<210>  137
<211>  37
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  137

Ser Gln His Thr Gln Pro Thr Pro Glu Pro Ser Thr Ala Pro Ser Thr 
1               5                   10                  15      


Ser Phe Leu Leu Pro Met Gly Pro Ser Pro Pro Ala Glu Gly Ser Thr 
            20                  25                  30          


Gly Asp Glu Pro Lys 
        35          


<210>  138
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  138

Ser Leu Ser Leu Ser Pro Gly Lys Ser Glu 
1               5                   10  


<210>  139
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  139

Glu Glu Met Thr Lys Asn Gln Val 
1               5               


<210>  140
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  140

Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys 
1               5                   10                  


<210>  141
<211>  41
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  141

Ser Gln His Thr Gln Pro Thr Pro Glu Pro Ser Thr Ala Pro Ser Thr 
1               5                   10                  15      


Ser Phe Leu Leu Pro Met Gly Pro Ser Pro Pro Ala Glu Gly Ser Thr 
            20                  25                  30          


Gly Asp Glu Pro Lys Ser Cys Asp Lys 
        35                  40      


<210>  142
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  142

Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly 
1               5                   10                  15      


<210>  143
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  143

Leu Arg Glu Tyr Tyr Asp Gln Thr Ala Gln Met Cys Cys Ser Lys 
1               5                   10                  15  


<210>  144
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  144

Cys Ser Ser Asp Gln Val Glu Thr Gln Ala Cys Thr Arg 
1               5                   10              


<210>  145
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  145

Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys 
1               5                   10                  15      


<210>  146
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  146

Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly 
1               5                   10      


<210>  147
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  147

Cys Ser Ser Asp Gln Val Glu Thr Gln Ala Cys Thr Arg 
1               5                   10              


<210>  148
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  148

Asn Gln Val Ser Leu Thr Cys Leu Val Lys 
1               5                   10  


<210>  149
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  149

Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg 
1               5                   10              


<210>  150
<211>  18
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  150

Pro Ala Gln Val Ala Phe Thr Pro Tyr Ala Pro Glu Pro Gly Ser Thr 
1               5                   10                  15      


Cys Arg 
        


<210>  151
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  151

Ser Leu Ser Leu Ser Pro Gly Lys Ser Glu Lys Asp Glu Leu 
1               5                   10                  


<210>  152
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  152

Ala Phe Thr Pro Tyr Ala Pro Glu Pro Gly Ser Thr Cys Arg 
1               5                   10                  


<210>  153
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  153

Ala Pro Gly Ala Val His Leu Pro Gln Pro Val Ser Thr Arg 
1               5                   10                  


<210>  154
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  154

Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys 
1               5                   10                  15  


<210>  155
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  155

Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly 
1               5                   10                  


<210>  156
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  156

Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn 
1               5                   10                  


<210>  157
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  157

Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg 
1               5                   10      


<210>  158
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  158

Ser Met Ala Pro Gly Ala Val His Leu Pro Gln Pro Val Ser Thr Arg 
1               5                   10                  15      


<210>  159
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  159

Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu 
1               5                   10                  15      


Glu Met Thr Lys 
            20  


<210>  160
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  160

Thr Pro Tyr Ala Pro Glu Pro Gly Ser Thr Cys Arg 
1               5                   10          


<210>  161
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  161

Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro Glu Val 
1               5                   10                  15      


Lys 
    


<210>  162
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  162

Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg 
1               5                   10              


<210>  163
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  163

Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys 
1               5                   10          


<210>  164
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  164

Leu Arg Glu Tyr Tyr Asp Gln Thr Ala Gln Met Cys Cys Ser Lys 
1               5                   10                  15  


<210>  165
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  165

Phe Thr Pro Tyr Ala Pro Glu Pro Gly Ser Thr Cys Arg 
1               5                   10              


<210>  166
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  166

Ser Met Ala Pro Gly Ala Val His Leu Pro Gln Pro Val Ser Thr Arg 
1               5                   10                  15      


<210>  167
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  167

Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys 
1               5                   10          


<210>  168
<211>  19
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  168

Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys 
1               5                   10                  15      


Glu Tyr Lys 
            


<210>  169
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  169

Ser Gln His Thr Gln Pro Thr Pro Glu Pro Ser Thr Ala Pro Ser 
1               5                   10                  15  


<210>  170
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  170

Ser Met Ala Pro Gly Ala Val His Leu Pro Gln Pro Val Ser 
1               5                   10                  


<210>  171
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  171

Ala Val His Leu Pro Gln Pro Val Ser Thr Arg 
1               5                   10      


<210>  172
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  172

Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg 
1               5                   10                  15  


<210>  173
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  173

Pro Gly Ala Val His Leu Pro Gln Pro Val Ser Thr Arg 
1               5                   10              


<210>  174
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  174

Thr Leu Met Ile Ser Arg 
1               5       


<210>  175
<211>  33
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  175

Lys Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser 
1               5                   10                  15      


Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr 
            20                  25                  30          


Lys 
    


<210>  176
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  176

Leu Arg Glu Tyr Tyr Asp Gln Thr Ala Gln Met Cys 
1               5                   10          


<210>  177
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  177

Ser Met Ala Pro Gly Ala Val His Leu Pro Gln Pro Val 
1               5                   10              


<210>  178
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  178

Leu Pro Ala Pro Ile Glu Lys 
1               5           


<210>  179
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  179

Glu Tyr Tyr Asp Gln Thr Ala Gln Met Cys Cys Ser Lys 
1               5                   10              


<210>  180
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  180

Asn Trp Val Pro Glu Cys Leu Ser Cys Gly Ser Arg 
1               5                   10          


<210>  181
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  181

Ser Leu Ser Pro Gly Lys Ser Glu Lys Asp Glu Leu 
1               5                   10          


<210>  182
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  182

Ile Cys Thr Cys Arg Pro Gly Trp Tyr Cys Ala Leu Ser Lys 
1               5                   10                  


<210>  183
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  183

Ser Met Ala Pro Gly Ala Val His Leu Pro Gln Pro Val Ser Thr 
1               5                   10                  15  


<210>  184
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  184

Glu Tyr Tyr Asp Gln Thr Ala Gln Met Cys Cys Ser Lys 
1               5                   10              


<210>  185
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  185

Ala Ser Met Asp Ala Val Cys Thr Ser Thr Ser Pro Thr Arg 
1               5                   10                  


<210>  186
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  186

Ser Gln His Thr Gln Pro Thr Pro Glu Pro Ser Thr Ala Pro Ser Thr 
1               5                   10                  15      


Ser 
    


<210>  187
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  187

Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys 
1               5                   10      


<210>  188
<211>  19
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  188

Ser Gln His Thr Gln Pro Thr Pro Glu Pro Ser Thr Ala Pro Ser Thr 
1               5                   10                  15      


Ser Phe Leu 
            


<210>  189
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  189

Thr Leu Met Ile Ser Arg 
1               5       


<210>  190
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  190

Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys 
1               5                   10                  15      


<210>  191
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  191

Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu 
1               5                   10                  15      


Glu Met Thr Lys 
            20  


<210>  192
<211>  21
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  192

Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro 
1               5                   10                  15      


Glu Val Lys Phe Asn 
            20      


<210>  193
<211>  18
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  193

Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu 
1               5                   10                  15      


Leu Gly 
        


<210>  194
<211>  22
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  194

Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln 
1               5                   10                  15      


Pro Glu Asn Asn Tyr Lys 
            20          


<210>  195
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  195

Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser 
1               5                   10                  15      


Arg 
    


<210>  196
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  196

Leu Arg Glu Tyr Tyr Asp Gln Thr Ala Gln Met Cys Cys 
1               5                   10              


<210>  197
<211>  18
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  197

Leu Pro Met Gly Pro Ser Pro Pro Ala Glu Gly Ser Thr Gly Asp Glu 
1               5                   10                  15      


Pro Lys 
        


<210>  198
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  198

Ser Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys 
1               5                   10                  15      


<210>  199
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  199

Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys 
1               5                   10                  


<210>  200
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  200

Pro Met Gly Pro Ser Pro Pro Ala Glu Gly Ser Thr Gly Asp Glu Pro 
1               5                   10                  15      


Lys 
    


<210>  201
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  201

Ser Met Ala Pro Gly Ala Val His Leu Pro Gln Pro Val Ser Thr Arg 
1               5                   10                  15      


<210>  202
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  202

Ser Met Ala Pro Gly Ala Val His Leu Pro Gln 
1               5                   10      


<210>  203
<211>  18
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Peptide degradation product derived from prh TNFR2:Fc (PRX106)

<400>  203

Leu Pro Met Gly Pro Ser Pro Pro Ala Glu Gly Ser Thr Gly Asp Glu 
1               5                   10                  15      


Pro Lys 
        


<210>  204
<211>  474
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PRX106

<400>  204

Ala Leu Pro Ala Gln Val Ala Phe Thr Pro Tyr Ala Pro Glu Pro Gly 
1               5                   10                  15      


Ser Thr Cys Arg Leu Arg Glu Tyr Tyr Asp Gln Thr Ala Gln Met Cys 
            20                  25                  30          


Cys Ser Lys Cys Ser Pro Gly Gln His Ala Lys Val Phe Cys Thr Lys 
        35                  40                  45              


Thr Ser Asp Thr Val Cys Asp Ser Cys Glu Asp Ser Thr Tyr Thr Gln 
    50                  55                  60                  


Leu Trp Asn Trp Val Pro Glu Cys Leu Ser Cys Gly Ser Arg Cys Ser 
65                  70                  75                  80  


Ser Asp Gln Val Glu Thr Gln Ala Cys Thr Arg Glu Gln Asn Arg Ile 
                85                  90                  95      


Cys Thr Cys Arg Pro Gly Trp Tyr Cys Ala Leu Ser Lys Gln Glu Gly 
            100                 105                 110         


Cys Arg Leu Cys Ala Pro Leu Arg Lys Cys Arg Pro Gly Phe Gly Val 
        115                 120                 125             


Ala Arg Pro Gly Thr Glu Thr Ser Asp Val Val Cys Lys Pro Cys Ala 
    130                 135                 140                 


Pro Gly Thr Phe Ser Asn Thr Thr Ser Ser Thr Asp Ile Cys Arg Pro 
145                 150                 155                 160 


His Gln Ile Cys Asn Val Val Ala Ile Pro Gly Asn Ala Ser Met Asp 
                165                 170                 175     


Ala Val Cys Thr Ser Thr Ser Pro Thr Arg Ser Met Ala Pro Gly Ala 
            180                 185                 190         


Val His Leu Pro Gln Pro Val Ser Thr Arg Ser Gln His Thr Gln Pro 
        195                 200                 205             


Thr Pro Glu Pro Ser Thr Ala Pro Ser Thr Ser Phe Leu Leu Pro Met 
    210                 215                 220                 


Gly Pro Ser Pro Pro Ala Glu Gly Ser Thr Gly Asp Glu Pro Lys Ser 
225                 230                 235                 240 


Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu 
                245                 250                 255     


Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu 
            260                 265                 270         


Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser 
        275                 280                 285             


His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu 
    290                 295                 300                 


Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr 
305                 310                 315                 320 


Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn 
                325                 330                 335     


Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro 
            340                 345                 350         


Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln 
        355                 360                 365             


Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val 
    370                 375                 380                 


Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val 
385                 390                 395                 400 


Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro 
                405                 410                 415     


Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr 
            420                 425                 430         


Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val 
        435                 440                 445             


Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu 
    450                 455                 460                 


Ser Pro Gly Lys Ser Glu Lys Asp Glu Leu 
465                 470                 


<210>  205
<211>  472
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PRX106

<400>  205

Pro Ala Gln Val Ala Phe Thr Pro Tyr Ala Pro Glu Pro Gly Ser Thr 
1               5                   10                  15      


Cys Arg Leu Arg Glu Tyr Tyr Asp Gln Thr Ala Gln Met Cys Cys Ser 
            20                  25                  30          


Lys Cys Ser Pro Gly Gln His Ala Lys Val Phe Cys Thr Lys Thr Ser 
        35                  40                  45              


Asp Thr Val Cys Asp Ser Cys Glu Asp Ser Thr Tyr Thr Gln Leu Trp 
    50                  55                  60                  


Asn Trp Val Pro Glu Cys Leu Ser Cys Gly Ser Arg Cys Ser Ser Asp 
65                  70                  75                  80  


Gln Val Glu Thr Gln Ala Cys Thr Arg Glu Gln Asn Arg Ile Cys Thr 
                85                  90                  95      


Cys Arg Pro Gly Trp Tyr Cys Ala Leu Ser Lys Gln Glu Gly Cys Arg 
            100                 105                 110         


Leu Cys Ala Pro Leu Arg Lys Cys Arg Pro Gly Phe Gly Val Ala Arg 
        115                 120                 125             


Pro Gly Thr Glu Thr Ser Asp Val Val Cys Lys Pro Cys Ala Pro Gly 
    130                 135                 140                 


Thr Phe Ser Asn Thr Thr Ser Ser Thr Asp Ile Cys Arg Pro His Gln 
145                 150                 155                 160 


Ile Cys Asn Val Val Ala Ile Pro Gly Asn Ala Ser Met Asp Ala Val 
                165                 170                 175     


Cys Thr Ser Thr Ser Pro Thr Arg Ser Met Ala Pro Gly Ala Val His 
            180                 185                 190         


Leu Pro Gln Pro Val Ser Thr Arg Ser Gln His Thr Gln Pro Thr Pro 
        195                 200                 205             


Glu Pro Ser Thr Ala Pro Ser Thr Ser Phe Leu Leu Pro Met Gly Pro 
    210                 215                 220                 


Ser Pro Pro Ala Glu Gly Ser Thr Gly Asp Glu Pro Lys Ser Cys Asp 
225                 230                 235                 240 


Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly 
                245                 250                 255     


Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile 
            260                 265                 270         


Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu 
        275                 280                 285             


Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His 
    290                 295                 300                 


Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg 
305                 310                 315                 320 


Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys 
                325                 330                 335     


Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu 
            340                 345                 350         


Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr 
        355                 360                 365             


Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu 
    370                 375                 380                 


Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp 
385                 390                 395                 400 


Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val 
                405                 410                 415     


Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp 
            420                 425                 430         


Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His 
        435                 440                 445             


Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro 
    450                 455                 460                 


Gly Lys Ser Glu Lys Asp Glu Leu 
465                 470         


